HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies

Human epidermal growth factor receptor-2 (HER2)-expression gastro-oesophageal adenocarcinomas (GEA) gained interest as an important target for therapy with trastuzumab. In the current review, we focused the current knowledge on HER2 status in dysplastic and neoplastic gastric conditions, analyzing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ieni, Antonio, Cardia, Roberta, Pizzimenti, Cristina, Zeppa, Pio, Tuccari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151629/
https://www.ncbi.nlm.nih.gov/pubmed/32098203
http://dx.doi.org/10.3390/jpm10010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151629/
https://www.ncbi.nlm.nih.gov/pubmed/32098203
http://dx.doi.org/10.3390/jpm10010010

Ejemplares similares